Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immune-stimulating humanized monoclonal antibodies against human interleukin-2, and fusion proteins thereof

Immune-stimulating humanized monoclonal antibodies against human interleukin-2, and fusion proteins thereof

US Patent 11851484 · Granted Dec 26, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric a2025
Variant CD58 domains and uses thereof2024
Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 bin2024
Method of treating cancer by administering immune effector cells expressing a ch2024
Immune-stimulating IL-2 fusion proteins2023
Method of detecting TIM-3 using antibody molecules to TIM-32021
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric a2021
IL-18 binding molecules2021
Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 bin2021
Antibody molecules to TIM-3 and uses thereof2021
Immune-stimulating monoclonal antibodies against human interleukin-22021
Immune-stimulating monoclonal antibodies against human interleukin-22021